Adjuvant effect of synthetic oligodeoxyribonucleotides (CpG-ODN) from the Paracoccidioides brasiliensis gp43 gene on the Th2-Th1 immunomodulation of experimental paracoccidioidomycosis

Scandinavian Journal of Immunology

Volumn 62, Issue 4, 2005, Pages 325-333

  Amaral, C C ^a   Garcia, I P ^a   Fernandes, G F ^a   Almeida, S R ^b   Camargo, Z P ^a   Souza, M C ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE METODISTA DE SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN; GLYCOPROTEIN GP 43; IMMUNOGLOBULIN G2A; INTERLEUKIN 12; INTERLEUKIN 4; OLIGODEOXYRIBONUCLEOTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CPG ISLAND; CYTOKINE RELEASE; FUNGAL GENE; IMMUNOMODULATION; INFECTION SENSITIVITY; MOUSE; NONHUMAN; PARACOCCIDIOIDES BRASILIENSIS; PRIORITY JOURNAL; PROVOCATION TEST; SOUTH AMERICAN BLASTOMYCOSIS; SPECIES COMPARISON; SURVIVAL RATE; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FUNGAL PROTEINS; GENES, FUNGAL; GLYCOPROTEINS; LYMPH NODES; MICE; OLIGODEOXYRIBONUCLEOTIDES; PARACOCCIDIOIDES; PARACOCCIDIOIDOMYCOSIS; SPLEEN; TH1 CELLS; TH2 CELLS;

EID: 27644469854     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2005.01680.x     Document Type: Article

References (52)

1. McEwen J, Bedoa V, Patiño MM, Salazar ME, Restrepo AM. Experimental marine paracoccidioidomycosis induced by inhalation of conidia. J Med Vet Mycol 1987;25:165-7.
2. San Blas G. Paracoccidioidomycosis and its etiological agent Paracoccidioides brasiliensis. J Med Vet Mycol 1993;31:99-113.
3. Almeida SR, Moraes JZ, Camargo ZP, Gesztesi JL, Mariano M, Lopes JD. Pattern of immune response to gp43 form Paracoccidioides brasiliensis in susceptible and resistant mice is influenced by antigen-presenting cells. Cell Immunol 1998;190:68-76.
4. Franco M, Montenegro MR, Mendes RP, Marques AS, Dillon NL, Mota NS. Paracoccidioidomycosis: a recently proposed classification of its clinical forms. Rev Soc Bras Med Trop 1987;20:129-32.
5. Arango M, Yarzabal L. T-cell dysfunction and hyperimmunoglobulinemia E in paracoccidioidomycosis. Mycopathologia 1982;79:115-23.
6. Franco MF, Mendes RP, Moscardi-Bacchi M, Rezkallah-Iwasso MT, Montenegro MR. Paracoccidioidomycosis. Bailliere's Clin Trop Med Commun Dis 1989;4:185-200.
7. Mota NGS, Peraçoli MTS, Mendes RP et al. Mononuclear subsets in patients with different clinical forms of paracoccidioidomycosis. J Med Vet Mycol 1988;26:105-11.
8. Benard G, Mendes-Giannini MJS, Juvenale M, Miranda ET, Duarte AJS. Immunosuppression in paracoccidioidomycosis: T cell hyporesponsiveness to two Paracoccidioides brasiliensis glycoproteins that elicit strong humoral response. J Infect Dis 1997;175:1263-7.
9. Calich VLG, Singer-Vermes LM, Siqueira AM, Burger E. Susceptibility and resistance of inbred mice to Paracoccidioides brasiliensis. Br J Exp Pathol 1985;66:585-94.
10. Singer-Vermes LM, Caldeira CB, Burger E et al. Experimental Paracoccidioidomycosis, relationship among the dissemination of the infection, humoral and cellular immune responses. Clin Exp Immunol 1993;94:75-9.
11. Uwiera RRE, Gerdts V, Pontarollo RA, Babiuk LA, Middleton DM, Griebel PJ. Plamid DNA induces increased lymphocyte trafficking: a specific role for CpG motifs. Cell Immunol 2001;214:155-64.
12. Medzhitov R, Janeway CA Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997;91:295-8.
13. Wagner H. Interactions between bacterial CpG-DNA and TLR9 bridge innate and adaptive immunity. Curr Opin Microbiol 2002;5:62-9.
14. Yi AK, Krieg AM. Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA J Immunol 1998;161:4493-7.
15. Krieg AM, Yi AK, Matson S et al. CpG motifs in bacterial DNA trigger direct B cell activation. Nature 1995;374:546-69.
16. Ballas ZK, Rasmussen WL, Krieg AM. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol 1996;157:1840-5.
17. Sato Y, Roman M, Tighe H, Lee D, Nguyen MD, Silverman GJ. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 1996;273:352-4.
18. Klinman DM, Barnhart KM, Conover J. CpG motifs as immune adjuvants. Vaccine 1999;17:19-25.
19. Oxenius A, Martinic MMA, Hengartner H, Klenerman P. CpG containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines. J Virol 1999;73:4120-6.
20. Elkins KL, Rhinehart-Jones TR, Stibitz S, Conover JS, Klinman DM. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J Immunol 1999;162:2291-8.
21. Krieg AM, Love-Homan L, Yi A, Harty JT. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J Immunol 1998;16:2428-34.
22. Zimmermann S, Egeter O, Hausmann S, Lipford GB, Rocken M, Wagner H. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J Immunol 1998;15:3627-30.
23. Singer-Vermes LM, Ciavaglia MC, Kashino SS, Burguer E, Calich VLG. The source of the growth-promoting factor(s) affects the plating efficiency of Paracoccidioides brasiliensis. J Med Vet Mycol 1992;30:261-4.
24. Souza MC, Corrêa M, Almeida SR, Lopes JD, Camargo ZP. Immunostimulatory DNA from Paracoccidioides brasiliensis acts as T-helper 1 promoter in susceptible mice. Scand J Immunol 2001;54:348-56.
25. Calich VL, Kashino SS. Cytokines produced by susceptible and resistant mice in the course of Paracoccidioides brasiliensis infection. Braz J Med Biol Res 1998;31:615-23.
26. Cano LE, Kashino SS, Arruda C et al. Protective role of gamma interferon in experimental pulmonary paracoccidioidomycosis. Infect Immun 1998;66:800-6.
27. Baida H, Biselli PJ, Juvenale M et al. Differential antibody isotype expression to the major Paracoccidioides brasiliensis antigen in juvenile and adult form of paracoccidioidomycosis. Microbes Infect 1999;1:273-8.
28. Hostetler JS, Brummer E, Coffman RL. Stevens DA. Effect of anti-IL4, interferon-gamma and an antifungal triazole (SCH42427) in paracoccidioidomycosis: correlation of IgE levels with the outcome. Clin Exp Immunol 1993;94:11-6.
29. Yamamoto S, Yamamoto T, Kataoka T, Kuramoto E, Yano O, Tokunaga T. Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J Immunol 1992;148:4072-6.
30. Lipford GB, Bauer M, Blank C, Reiter R, Wagner H, Heeg K. CpG containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants. Eur J Immunol 1997;27:2340-4.
31. Spellberg B, Edwards JE. Type 1/ Typ2 immunity in infectious diseases. Clin Infect Dis 2001;32:76-102.
32. Smith JM, Griffin JF. Strategies for the development of a vaccine against ringworm. J Med Vet Mycol 1995;33:87-91.
33. Sadick MD, Lockslwy RM, Tubbs C, Raff HV. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate IFN-γ in response to Leishmania antigens 'in vitro'. J Immunol 1986;136:655-61.
34. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. Reciprocal expression of interferon gamma or interleukin 4 during the resolution of progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med 1989;169:59-72.
35. Rossi-Bergmann B, Muller I, Godinho EB. Th1 and Th2 T-cell subsets are differentially activated by macrophages and B cells in murine leishmaniasis. Infect Immun 1993;61:2266-9.
36. Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol 1995;13:151-77.
37. Walker KB, Butler R, Colstons MJ. Role of Th-1 lymphocytes in the development of protective immunity against Mycobacterium leprae. J Immunol 1992;148:1885-9.
38. Afonso LC, ScharTon TM, Vieira LQ, Wsocka M, Trinchieri SP. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 1994;263:235-7.
39. Romano CC, Mendes-Giannini MJS, Duarte AJS, Benard G. IL-12 and neutralization of endogenous IL-10 revert the in vitro antigen-specific cellular immunosuppression of paracoccidioidomycosis patients. Cytokine 2002;18 (3):149-57.
40. Nascimento FR, Calich VL, Roriguez D, Russo M. Dual role for nitric oxide in paracoccidioidomycosis: essential for resistance, but overproduction associated with susceptibility. J Immunol 2002;168:4593-600.
41. Orange JS, Wolf SF, Biron CA. Effects of IL-12 on the response and susceptibility to viral infections. J Immunol 1994;152:1253-64.
42. Zhou P, Sieve MC, Bennet J, Kwon-Chung KJ, Tewari RP, Gazzinelli RT. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through the induction of IFN-gamma. J Immunol 1995;155:785-95.
43. Hunter CA, Candolfi E, Subauste C, Van Cleave V, Remington JS. Studies on the role of interleukin-12 in acute murine toxoplasmosis. Immunology 1995;84:16-20.
44. Kashino SS, Fazioli RA, Moscardi-Bacchi M, Franco M, Singer-Vermes LM, Burger E. Effect of macrophage blockade on resistance mechanisms of inbred mice to Paracoccidioides brasiliensis infection. Mycopathologia 1995;130:131-40.
45. Kashino SS, Faziolli RA, Cafalli-Favati C et al. Resistance to Paracoccidioides brasiliensis infection is linked to a preferential Th1 immune response, whereas susceptibility is associated with to absence of interferon-gamma production. J Interferon Cytokine Res 2000;20:89-97.
46. Romagnani S. T-cell subsets. (Th1 Versus Th2). Immunol Today 1997;18:263-6.
47. Krug A, Rothenfusser S, Selinger S, Boch C, Kerkmann M, Battiany J. CpG-A oligonucleotides induce a monocyte-derived dendritic cell-like phenotype that preferentially activates CDS T cells. J Immunol 2003;170:3468-77.
48. Miyaji M, Nishimura K. Granuloma formation and killing functions of granuloma congenitally athymic nude mice infected with Blastomyces dermatitidis and Paracoccidioides brasiliensis. Mycopathologia 1983;82:129-41.
49. Burger E, Vaz CCA, Sano A, Calich VLG, Singer-Vermes LM, Xidieh CF. Paracoccidioides brasiliensis infection in nude mice: studies with isolates differing in virulence and definition of their T-Cell dependent and T-Cell independent components. Am J Trop Med Hyg 1996;55:391-8.
50. De Brito T, Franco MF. Granulomatous inflammation. Rev Inst Med Trop Sao Paulo 1994;36:185-92.
51. Klinman DM, Conover J, Coban C. Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection. Infect Immun 1999;67:5658-63.
52. Gramzinski RA, Doolan DL, Sedegah M, Davis HL, Krieg AM, Hoffman SL. Interleukin-12 and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice. Infect Immun 2001;69:1643-9.